Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP921441.RANWe9tdwjsokalydBI0s9XqNrBHlLhudkJMeYGhfgXKs130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP921441.RANWe9tdwjsokalydBI0s9XqNrBHlLhudkJMeYGhfgXKs130_assertion type Assertion NP921441.RANWe9tdwjsokalydBI0s9XqNrBHlLhudkJMeYGhfgXKs130_head.
- NP921441.RANWe9tdwjsokalydBI0s9XqNrBHlLhudkJMeYGhfgXKs130_assertion description "[In this study, we evaluated the ability of ATN-161 (Ac-PHSCN-NH2), a 5-mer capped peptide derived from the synergy region of fibronectin that binds to alpha5beta1 and alphavbeta3 in vitro, to block breast cancer growth and metastasis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP921441.RANWe9tdwjsokalydBI0s9XqNrBHlLhudkJMeYGhfgXKs130_provenance.
- NP921441.RANWe9tdwjsokalydBI0s9XqNrBHlLhudkJMeYGhfgXKs130_assertion evidence source_evidence_literature NP921441.RANWe9tdwjsokalydBI0s9XqNrBHlLhudkJMeYGhfgXKs130_provenance.
- NP921441.RANWe9tdwjsokalydBI0s9XqNrBHlLhudkJMeYGhfgXKs130_assertion SIO_000772 16985061 NP921441.RANWe9tdwjsokalydBI0s9XqNrBHlLhudkJMeYGhfgXKs130_provenance.
- NP921441.RANWe9tdwjsokalydBI0s9XqNrBHlLhudkJMeYGhfgXKs130_assertion wasDerivedFrom befree-20140225 NP921441.RANWe9tdwjsokalydBI0s9XqNrBHlLhudkJMeYGhfgXKs130_provenance.
- NP921441.RANWe9tdwjsokalydBI0s9XqNrBHlLhudkJMeYGhfgXKs130_assertion wasGeneratedBy ECO_0000203 NP921441.RANWe9tdwjsokalydBI0s9XqNrBHlLhudkJMeYGhfgXKs130_provenance.